Correlation Between Clearmind Medicine and Scisparc

Can any of the company-specific risk be diversified away by investing in both Clearmind Medicine and Scisparc at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Clearmind Medicine and Scisparc into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Clearmind Medicine Common and Scisparc, you can compare the effects of market volatilities on Clearmind Medicine and Scisparc and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Clearmind Medicine with a short position of Scisparc. Check out your portfolio center. Please also check ongoing floating volatility patterns of Clearmind Medicine and Scisparc.

Diversification Opportunities for Clearmind Medicine and Scisparc

0.25

Correlation Coefficient

Clearmind Medicine  Scisparc

Modest diversification

The 3 months correlation between Clearmind and Scisparc is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Clearmind Medicine Common and Scisparc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Scisparc and Clearmind Medicine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Clearmind Medicine Common are associated (or correlated) with Scisparc. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Scisparc has no effect on the direction of Clearmind Medicine i.e., Clearmind Medicine and Scisparc go up and down completely randomly.

Pair Corralation between Clearmind Medicine and Scisparc

Given the investment horizon of 90 days Clearmind Medicine Common is expected to generate 1.1 times more return on investment than Scisparc. However, Clearmind Medicine is 1.1 times more volatile than Scisparc. It trades about 0.04 of its potential returns per unit of risk. Scisparc is currently generating about -0.06 per unit of risk. If you would invest  97.00  in Clearmind Medicine Common on May 15, 2025 and sell it today you would earn a total of  5.00  from holding Clearmind Medicine Common or generate 5.15% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Clearmind Medicine Common  vs.  Scisparc

Clearmind Medicine Common

Risk-Adjusted Performance

Soft

Compared to the overall equity markets, risk-adjusted returns on investments in Clearmind Medicine Common are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Clearmind Medicine may actually be approaching a critical reversion point that can send shares even higher in September 2025.

Scisparc

Risk-Adjusted Performance

Weakest

Over the last 90 days Scisparc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in September 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Clearmind Medicine and Scisparc

The main advantage of trading using opposite Clearmind Medicine and Scisparc positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Clearmind Medicine position performs unexpectedly, Scisparc can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Scisparc will offset losses from the drop in Scisparc's long position.

The idea behind Clearmind Medicine Common and Scisparc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.